Mednet Logo
HomeNeurologyQuestion

How do you manage glioblastoma presenting with leptomeningeal dissemination?

2
5 Answers
Mednet Member
Mednet Member
Radiation Oncology · University of Pittsburgh

Hospice is a very legitimate option. As physicians, we recommend this far too infrequently.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic

In an older person with poor PS who is not symptomatic from the leptomeningeal disease, they are still more likely to suffer from their primary tumor so I think it is reasonable to just ignore it.

I think performance status and prognosis (age, MGMT) are critical. One could argue for a trial of TMZ a...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Geisinger

Have a serious discussion about prognosis, getting affairs in order, and end-of-life care.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

Considered initially a rare complication in gliomas, the incidence of LMD is estimated at 4%, reaching 25% on postmortem neuropathological evaluation. There is no standard-of-care treatment for LMS in patients with GBM, although multiple groups have proposed several therapeutic options (e.g., methot...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · MD Anderson Cancer Center

I'd be eager to hear from other neuro-oncologists on this but generally, in my practice, similar to without LMD. Our chemotherapeutic agents are BBB penetrants, and IT cytotoxic chemotherapy only penetrates a couple of millimeters (so would not address the parenchymal disease). Having said this, I'm...

Register or Sign In to see full answer

How do you manage glioblastoma presenting with leptomeningeal dissemination? | Mednet